journal
Evidence pageMesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World (Fernández-Garza LE, et al., Pharmaceuticals 16(9):1334)
Pharmaceuticals (MDPI)
Published Sep 21, 2023accessed Sep 18, 2026Updated Sep 19, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC10536665/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Not yet verified |
| Evidence level | — |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (9)
FactAdipose-derived Stem Cell: Korea MFDS approvals = Queencell (Anterogen, autologous, subcutaneous tissue defects, 2010); Cupistem (Anterogen, autologous, Crohn's fistula, 2012)FactAdipose-derived Stem Cell: US FDA approval status = No adipose-derived MSC product listed as FDA-approved in a 2023 review of approved MSC therapies worldwideAnswerIs stem cell therapy FDA approved?AnswerWhat conditions can stem cell therapy treat?AnswerWhat are the risks of stem cell therapy?AnswerHow do I know if a stem cell clinic is legitimate?AnswerIs stem cell therapy legal in South Korea?Answer줄기세포 의료, 현재 실제 치료에 쓰이는 분야는 어디까지인가요?ArticleStem Cell Therapy: Established Uses, Approved Products, Risks and How to Check a Treatment